Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets
               
    As of December 31,  
    2022     2021  
Deferred tax assets:                
Net operating loss carryforwards   $ 57,895     $ 62,097  
Research credit carryforwards     10,521       14,738  
Other, net     1,968       1,113  
Total deferred tax assets     70,384       77,948  
Deferred tax liabilities:                
Other, net     (46 )     (65 )
Total deferred tax liabilities     (46 )     (65 )
Valuation allowance     (70,338 )     (77,883 )
Net deferred tax assets   $ -     $ -  
Schedule of effective tax rate
               
    For the
Years Ended
December 31,
 
    2022     2021  
Computed at 21%   $ (2,144 )   $ (1,842 )
State taxes     (488 )     (67 )
Change in valuation allowance     (7,545 )     (1,939 )
Other     -       3  
Stock based compensation     627       -  
Research and development credits     3,489       (9 )
Tax attributes expirations     6,216       3,767  
Impact of IRC 162m     (159 )     87  
Total   $ (4 )   $ -